Abstract
Analogs of pyrrhocoricin, a proline-rich antibacterial peptide with a potential therapeutic use, show multiple actions on bacterial cells. We used a dual-fluorochrome membrane viability assay to provide evidence that the lead drug candidate, Pip-pyrr-MeArg dimer derivative, kills bacteria better than the native peptide due to an improved activity on bacterial membranes. This assay was also instrumental in documenting that activity on bacterial membranes and toxicity to human cells can be correlated, and the predominant mode of action can be changed from intracellular DnaK inhibition to membrane disintegration. Similar analyses with an alanine-scan on pyrrhocoricin identified Lys3 as a crucial player to interaction with bacterial membranes, three prolines in mid-chain position as being responsible for maintaining structural integrity and Asp2, Tyr6, Leu7, and Arg9 as putative contact points to the D-E helix of the bacterial target protein DnaK.
Similar content being viewed by others
References
Friedrich, C.L., Moyles, D., Beveridge, T.J. and Hancock, R.E., Antimicrob. Agents Chemother., 44 (2000) 2086.
Steiner, H., Andreu, D. and Merrifield, R.B., Biochim. Biophys. Acta, 939 (1988) 260.
Cociancich, S., Ghazi, A., Hetru, C., Hoffmann, J.A. and Letellier, L., J. Biol. Chem., 268 (1993) 19239.
Wimley, W.C., Selsted, M.E. and White, S.H., Protein Sci., 3 (1994) 1361.
Ludtke, S., He, K. and Huang, H., Biochemistry, 34 (1995) 16764.
Marassi, F.M., Opella, S.J., Juvvadi, P. and Merrifield, R.B., Biophys. J., 77 (1999) 3152.
Andreu, D. and Rivas, L., Biopolymers, 47 (1998) 415.
Cudic, M. and Otvos, L., Jr., Curr. Drug Targets, 3 (2002) 101.
Gennaro, R., Zanetti, M., Benincasa, M., Podda, E. and Miani, M., Curr. Pharm. Des., 8 (2002) 763.
Park, C.B., Kim, H.S. and Kim, S.C., Biochem. Biophys. Res. Commun., 244 (1998) 253.
Cuoto, M.A., Harwig, S.S. and Lehrer, R.I., Infect. Immun., 274 (1993) 32555.
Kragol, G., Lovas, S., Varadi, G., Condie, B.A., Hoff-mann, R. and Otvos, L., Jr., Biochemistry, 40 (2001) 3016.
DeNardo, A., Vitiello, A. and Gallo, R.L., J. Immunol., 170 (2003) 2274.
Scott, M.G., Davidson, D.J., Gold, M.R., Bowdish, D. and Hancock, R.E.W., J. Immunol., 169 (2002) 3883.
Boman, H.G., Annu. Rev. Immunol., 13 (1995) 61.
Meister, M., Lemaitre, B. and Hoffmann, J.A., BioEssays, 19 (1997) 1019.
Uttenweiler-Joseph, S., Moniatte, M., Lagueux, M., Van Dorsselaer, A., Hoffmann, J.A. and Bulet, P., Proc. Natl. Acad. Sci. USA, 95 (1998) 11342.
Otvos, L., Jr., Cell. Mol. Life Sci., 59 (2002) 1138.
Bulet, P., Urge, L., Ohresser, S., Hetru, C. and Otvos, L., Jr., Eur. J. Biochem., 238 (1996) 64.
Hoffmann, R., Bulet, P., Urge, L. and Otvos, L., Jr., Biochim. Biophys. Acta, 1426 (1999) 459.
McManus, A., Otvos, L., Jr., Hoffmann, R. and Craik, D.J., Biochemistry, 38 (1999) 705.
Otvos, L., Jr., Bokonyi, K., Varga, I., Otvos, B.I., Hoff-mann, R., Ertl, H.C.J., Wade, J.D., McManus, A.M., Craik, D.J. and Bulet, P., Protein Sci., 9 (2000) 742.
Kragol, G., Hoffmann, R., Chattergoon, M.A., Lovas, S., Cudic, M., Bulet, P., Condie, B.A., Rosengren, K.J., Montaner, L.J. and Otvos, L., Jr., Eur. J. Biochem., 269 (2002) 4226.
Otvos, L., Jr., O, I., Rogers, M.E., Consolvo, P.J., Condie, B.A., Lovas, S., Bulet, P., O, I. and Blaszczyk-Thurin, M., Biochemistry, 39 (2000) 14150.
Bencivengo, A.-M., Cudic, M., Hoffmann, R. and Otvos, L., Jr., Lett. Pept. Sci., 8 (2001) 201.
Cudic, M., Condie, B.A., Weiner, D.J., Lysenko, E.S., Xiang, Z.Q., O, I., Bulet, P. and Otvos, L., Jr., Peptides, 23 (2002) 271.
Cudic, M., Lockatell, C.V., Johnson, D.E. and Otvos, L., Jr., Peptides, 24 (2003) 807.
Fields, G.B. and Noble, R.L., Int. J. Pept. Protein Res., 35 (1990) 161.
Winans, K.A., King, D.S., Rao, V.R. and Bertozzi, C.R., Biochemistry, 38 (1999) 11700.
Park, C.B., Yi, K., Matsuzaki, K., Kim, M.S. and Kim, S.C., Proc. Natl. Acad. Sci., USA, 97 (2000) 8245.
Mayo, K.H., Haseman, J., Young, H.C., and Mayo, J.W., Biochem. J., 349 (2000) 717.
Peschel, A., Trends Microbiol., 10 (2000) 179.
Ferreira, N.L. and Alix, J.-H., J. Bacteriol., 184 (2002)7047.
Otvos, L., Jr., J. Pept. Sci., 6 (2000) 497.
Zhang, L., Benz, R. and Hancock, R.E.W., Biochemistry, 38 (1999) 8102.
Park, C.B., Kim, M.S. and Kim, S.C., Biochem. Biophys. Res. Commun., 218 (1996) 408.
Matsuzaki, K., Biochim. Biophys. Acta, 1376 (1998) 391.
Ofran, Y. and Rost, B., J. Mol. Biol., 325 (2003) 377.
Klootwijk, W., Sleddens-Linkels, E., de Boer, R., Jansen, C.A., Autar, R., de Herder, W.W., Boeve, E.R., Visser, T.J. and de Greef, W.J., J. Clin. Endocrinol. Metab., 82 (1997) 3068.
Takeshima, K., Chikushi, A., Lee,, K.K., Yonnehara, S. and Matsuzaki, K., J. Biol. Chem., 278 (2003) 1310.
Hancock, R.E.W. and Lehrer, R., Trends Biotechnol., 16 (1998) 82.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bower, M.A., Cudic, M., Campbell, W. et al. Walking the fine line between intracellular and membrane activities of antibacterial peptides. Int J Pept Res Ther 10, 463–473 (2003). https://doi.org/10.1007/s10989-004-2405-8
Issue Date:
DOI: https://doi.org/10.1007/s10989-004-2405-8